Opus Genetics is trading at $3.00 (-12.02%) in pre-market following a sharp pullback from its July 28 close of $3.41.
- The downward move is described as a normal consolidation phase following a recent three-day rally.
- There are no company-specific announcements, earnings releases, or major events driving the price action.
- While broader market sentiment is mixed, there is no clear evidence that macroeconomic news is fueling the pre-market drop.